K. Dornbusch

1.3k total citations
47 papers, 1.1k citations indexed

About

K. Dornbusch is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, K. Dornbusch has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 18 papers in Molecular Medicine and 14 papers in Epidemiology. Recurrent topics in K. Dornbusch's work include Antibiotic Resistance in Bacteria (18 papers), Antibiotics Pharmacokinetics and Efficacy (17 papers) and Bacterial Identification and Susceptibility Testing (10 papers). K. Dornbusch is often cited by papers focused on Antibiotic Resistance in Bacteria (18 papers), Antibiotics Pharmacokinetics and Efficacy (17 papers) and Bacterial Identification and Susceptibility Testing (10 papers). K. Dornbusch collaborates with scholars based in Sweden, France and United Kingdom. K. Dornbusch's co-authors include Maud Nilsson, Måns Nilsson, Lennart E. Nilsson, Ida Karlsson, Hans O. Hallander, Lena Gezelius, Kalen Jacobson, C. E. Nord, B Olsson-Liljequist and G Kronvall and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and European Journal of Clinical Microbiology & Infectious Diseases.

In The Last Decade

K. Dornbusch

46 papers receiving 964 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Dornbusch Sweden 16 593 306 305 214 200 47 1.1k
A Buré France 14 433 0.7× 249 0.8× 312 1.0× 270 1.3× 125 0.6× 45 884
V. Krčméry Slovakia 12 841 1.4× 224 0.7× 389 1.3× 193 0.9× 169 0.8× 99 1.3k
A. Péchinot France 17 378 0.6× 206 0.7× 319 1.0× 197 0.9× 131 0.7× 61 1.0k
Mark E. Jones United States 13 743 1.3× 210 0.7× 402 1.3× 170 0.8× 226 1.1× 14 1.2k
R. E. Warren United Kingdom 14 621 1.0× 157 0.5× 419 1.4× 420 2.0× 229 1.1× 20 1.3k
Kathrine Dornbusch Sweden 14 370 0.6× 144 0.5× 153 0.5× 242 1.1× 184 0.9× 41 754
Marie-Dominique Kitzis France 19 799 1.3× 683 2.2× 523 1.7× 411 1.9× 198 1.0× 48 1.5k
Ioanna Stefanou Greece 12 663 1.1× 366 1.2× 306 1.0× 141 0.7× 177 0.9× 16 909
C Tancrède France 21 419 0.7× 161 0.5× 390 1.3× 472 2.2× 119 0.6× 47 1.5k
A Gouby France 14 420 0.7× 165 0.5× 331 1.1× 189 0.9× 120 0.6× 25 950

Countries citing papers authored by K. Dornbusch

Since Specialization
Citations

This map shows the geographic impact of K. Dornbusch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Dornbusch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Dornbusch more than expected).

Fields of papers citing papers by K. Dornbusch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Dornbusch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Dornbusch. The network helps show where K. Dornbusch may publish in the future.

Co-authorship network of co-authors of K. Dornbusch

This figure shows the co-authorship network connecting the top 25 collaborators of K. Dornbusch. A scholar is included among the top collaborators of K. Dornbusch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Dornbusch. K. Dornbusch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nilsson, Maud, et al.. (2007). Multiplex PCR amplification assay for the detection of bla SHV, bla TEM and bla CTX‐M genes in Enterobacteriaceae. Apmis. 115(12). 1400–1408. 295 indexed citations
2.
3.
Engervall, Per, M. Kalin, K. Dornbusch, & Magnus Björkholm. (1999). Cefepime as Empirical Monotherapy in Febrile Patients with Hematological Malignancies and Neutropenia: A Randomized, Single-Center Phase II Trial. Journal of Chemotherapy. 11(4). 278–286. 11 indexed citations
4.
Arıkan, S., R Auckenthaler, Tom Bergan, et al.. (1996). Susceptibility testing of Haemophilus influenzae— an international collaborative study in quality assessment. Journal of Antimicrobial Chemotherapy. 38(3). 363–386. 8 indexed citations
5.
Wu, Shun‐Fan, K. Dornbusch, Mari Norgren, & G Kronvall. (1992). Extended spectrum β-lactamase from Klebsiella oxytoca, not belonging to the TEM or SHV family. Journal of Antimicrobial Chemotherapy. 30(1). 3–16. 20 indexed citations
6.
Dornbusch, K., et al.. (1991). Characterization of Klebsiella oxytoca septicaemia isolates resistant to aztreonam and cefuroxime. Journal of Antimicrobial Chemotherapy. 28(3). 389–397. 16 indexed citations
7.
8.
9.
Dornbusch, K., George H. Miller, R S Hare, & Karen Joy Shaw. (1990). Resistance to aminoglycoside antibiotics in Gram-negative bacilli and staphylococci isolated from blood. Report from a European collaborative study. Journal of Antimicrobial Chemotherapy. 26(1). 131–144. 55 indexed citations
10.
Dornbusch, K.. (1990). Resistance to β-lactam antibiotics and ciprofloxacin in Gram-negative bacilli and staphylococci isolated from blood: a European collaborative study. Journal of Antimicrobial Chemotherapy. 26(2). 269–278. 40 indexed citations
11.
Dornbusch, K., et al.. (1989). In-vitro activity of FCE 22101 against respiratory tract pathogens with reference to production of  -lactamases. Journal of Antimicrobial Chemotherapy. 23(suppl C). 31–41. 11 indexed citations
12.
Dornbusch, K., et al.. (1989). In-vitro activity of the new penems FCE 22101 and FCE 24362 alone or in combination with aminoglycosides against streptococci isolated from patients with endocarditis. Journal of Antimicrobial Chemotherapy. 23(suppl C). 109–117. 3 indexed citations
13.
Dornbusch, K., et al.. (1989). Comparative in-vitro activity of the penem FCE 22101 against recent European blood culture isolates. Journal of Antimicrobial Chemotherapy. 23(suppl C). 43–52. 5 indexed citations
14.
Machka, K., I. Braveny, H. Dabernat, et al.. (1988). Distribution and resistance patterns ofHaemophilus influenzae: A European cooperative study. European Journal of Clinical Microbiology & Infectious Diseases. 7(1). 14–24. 68 indexed citations
15.
Dornbusch, K., et al.. (1981). Influence of bacterial  -lactamase production on susceptibility in agar or broth to new cephalosporins. Journal of Antimicrobial Chemotherapy. 8(suppl B). 153–162. 4 indexed citations
16.
Dornbusch, K., et al.. (1979). Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 17–25. 34 indexed citations
17.
Dornbusch, K.. (1978). Antibiotics in bone tissues. Methodological and practical aspects.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 177–85. 14 indexed citations
18.
Ce, Nord, Berit Olsson, & K. Dornbusch. (1978). beta-lactamases in bacteroides.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 27–32. 8 indexed citations
19.
Bystedt, H, K. Dornbusch, & C. E. Nord. (1976). Concentrations of oxytetracycline, tetracycline and doxycycline in mandibular osteitis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37–41. 4 indexed citations
20.
Gnarpe, H, K. Dornbusch, & Olle Hägg. (1976). Doxycycline concentration levels in bone, soft tissue and serum after intravenous infusion of doxycycline. A clinical study.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 54–7. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Buré Breakdown of academic impact, for papers by V. Krčméry Breakdown of academic impact, for papers by A. Péchinot Breakdown of academic impact, for papers by Mark E. Jones Breakdown of academic impact, for papers by R. E. Warren Breakdown of academic impact, for papers by Kathrine Dornbusch Breakdown of academic impact, for papers by Marie-Dominique Kitzis Breakdown of academic impact, for papers by Ioanna Stefanou Breakdown of academic impact, for papers by C Tancrède Breakdown of academic impact, for papers by A Gouby
Rankless by CCL
2026